The innovation arm of Henry Ford Health is going national with DromosPTM, a tech platform designed to improve specialty pharmacy operations.
Henry Ford Health's innovation arm is going national with technology designed to improve specialty pharmacy operations.
Henry Ford Innovations has announced that the DromosPTM patient therapy management platform is now being used in seven health systems and specialty pharmacies across the country, and others are planning to integrate the technology in the months ahead.
“These partnerships allow increased functionality and provide patients across the country a better experience and care,” Lisa Prasad, the health system's chief innovation officer and leader of Henry Ford Innovations, said in a press release.
Developed in 2013 to help Henry Ford Health's own specialty pharmacy, Pharmacy Advantage, DromosPTM "fills a long-existing gap in the specialty pharmacy industry by offering efficient patient-focused care and service," officials said in the press release. It includes tools to help pharmacies take advantage of patient portals, find financial assistance for expensive prescriptions, improve medication monitoring, and identify best practices.
The licensing agreement for the technology is one of more than 30 that Henry Ford Innovations has enacted since its launch in 2011, representing more than $100 million in potential revenues for the health system.
Eric Wicklund is the associate content manager and senior editor for Innovation at HealthLeaders.